Unknown PHASE3 INTERVENTIONAL 2-arm NCT01581723

Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor

Using Biploar Technology for Transurethral Resection of Bladder Tumor - a Randomized Controlled Trial

Sponsor: Chinese University of Hong Kong

Interventions Bipolar diathermy Monopolar diathermy

Updated 6 times since 2017 Last updated: Feb 2, 2015 Started: May 31, 2012 Primary completion: Jun 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Urinary Bladder Tumor and is currently ongoing. Chinese University of Hong Kong leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shatin, Hong Kong
• Sheung Shui, Hong Kong